Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays

Clinica Chimica Acta

Volumn 412, Issue 3-4, 2011, Pages 370-375

  Hjortshøj, Søren ^a   Venge, Per ^b   Ravkilde, Jan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiac markers; Myocardial infarction; Point of care testing; Troponins

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ASSAY; BLOOD ANALYSIS; BLOOD SAMPLING; DIAGNOSTIC VALUE; FEMALE; HOSPITALIZATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; TROPONIN ASSAY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; CLINICAL LABORATORY TECHNIQUES; FEMALE; HEART; HUMANS; MALE; MIDDLE AGED; ORGAN SPECIFICITY; POINT-OF-CARE SYSTEMS; TROPONIN I;

EID: 78650253262     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.11.015     Document Type: Article

References (32)

1. Apple F.S., Jesse R.L., Newby L.K., Wu A.H., Christenson R.H. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007, 115:e352-e355.
2. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
3. Ilva T., Lund J., Porela P., et al. Early markers of myocardial injury: cTnI is enough. Clin Chim Acta 2009, 400:82-85.
4. Hjortshøj S., Dethlefsen C., Kristensen S.R., Ravkilde J. Improved assay of cardiac troponin I is more sensitive than other assays of necrosis markers. Scand J Clin Lab Investig 2008, 68:130-133.
5. Keller T., Zeller T., Peetz D., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361:868-877.
6. Giannitsis E., Becker M., Kurz K., Hess G., Zdunek D., Katus H.A. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010, 56:642-650.
7. Radiometer Medical A/S AQT FLEX analyzer, 928-986. 200806C 2009.
8. Apple F.S., Quist H.E., Doyle P.J., Otto A.P., Murakami M.M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003, 49:1331-1336.
9. Hedberg P., Wennecke G. A preliminary evaluation of the AQT90 FLEX TnI immunoassay. Clin Chem Lab Med 2009, 47:376-378.
10. Uettwiller-Geiger D., Wu A.H., Apple F.S., et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002, 48:869-876.
11. Venge P., James S., Jansson L., Lindahl B. Clinical performance of two highly sensitive cardiac troponin I assays. Clin Chem 2009, 55:109-116.
12. Abbott Diagnostics Abbott AxZym system:Troponin-I ADV Package Insert, 2J44 34-4081/R1 2009.
13. Panteghini M., Pagani F., Yeo K.T., et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004, 50:327-332.
14. Myocardial infarction redefined: A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000, 21:1502-1513.
15. James S., Flodin M., Johnston N., Lindahl B., Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem 2006, 52:832-837.
16. Apple F.S., Ler R., Chung A.Y., Berger M.J., Murakami M.M. Point-of-care i-STAT cardiac troponin i for assessment of patients with symptoms suggestive of acute coronary syndrome. Clin Chem 2006, 52:322-325.
17. Venge P., Lagerqvist B., Diderholm E., Lindahl B., Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 2002, 89:1035-1041.
18. Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009, 402:88-93.
19. Tate J.R., Ferguson W., Bais R., Kostner K., Marwick T., Carter A. The determination of the 99th centile level for troponin assays in an Australian reference population. Ann Clin Biochem 2008, 45:275-288.
20. Hruska R.E., Shih J. Cardiac Troponin Scorecard. Clin Chem 2009, 55:2230-2231.
21. Storti S., Prontera C., Parri M.S., et al. Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. Clin Chem Lab Med 2006, 44:1022-1029.
22. Kavsak P.A., MacRae A.R., Newman A.M., et al. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta 2007, 380:213-216.
23. Panteghini M., Apple F.S., Christenson R.H., Dati F., Mair J., Wu A.H. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry. Clin Chem Lab Med 1999, 37:687-693.
24. Wu A.H.B., Apple F.S., Gibler W.B., Jesse R.L., Warshaw M.M., Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999, 45:1104-1121.
25. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000, 36:970-1062.
26. Novis D.A., Jones B.A., Dale J.C., Walsh M.K. Biochemical markers of myocardial injury test turnaround time: A College of American Pathologists Q-Probes study of 7020 troponin and 4368 creatine kinase-MB determinations in 159 institutions. Arch Pathol Lab Med 2004, 128:158-164.
27. De Luca G., Suryapranata H., Ottervanger J.P., Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: Every minute of delay counts. Circulation 2004, 109:1223-1225.
28. Ryan R.J., Lindsell C.J., Hollander J.E., et al. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: The disposition impacted by serial point of care markers in acute coronary syndromes (DISPO-ACS) trial. Ann Emerg Med 2009, 53:321-328.
29. Collinson P.O., John C., Lynch S., et al. A prospective randomized controlled trial of point-of-care testing on the coronary care unit. Ann Clin Biochem 2004, 41:397-404.
30. Apple F.S., Chung A.Y., Kogut M.E., Bubany S., Murakami M.M. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin Chim Acta 2006, 370:191-195.
31. Singer A.J., Ardise J., Gulla J., Cangro J. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann Emerg Med 2005, 45:587-591.
32. Radiometer Medical A/S AQT90 FLEX TnI Test Kit Insert, 990-872. 200910P 2009.